Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.600
-0.050 (-1.89%)
At close: May 1, 2026, 4:00 PM EDT
2.548
-0.052 (-1.99%)
After-hours: May 1, 2026, 5:26 PM EDT
BDTX Market Cap
BDTX has a market cap or net worth of $148.95 million as of May 1, 2026. Its market cap has increased by 85.12% in one year.
Market Cap
148.95M
Enterprise Value
39.08M
1-Year Change
85.12%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $148.95M, a decrease of -89.01%. That is a compound annual growth rate of -29.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 151.82M | 9.65% |
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 163.00M |
| Tiziana Life Sciences | 159.53M |
| Molecular Partners AG | 158.33M |
| Alps Group | 156.07M |
| ProQR Therapeutics | 155.93M |
| Spero Therapeutics | 154.57M |
| Galectin Therapeutics | 152.72M |
| Fate Therapeutics | 151.14M |